Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1984 2
1985 2
1986 1
1988 1
1989 2
1990 1
1991 1
1993 2
1994 1
1995 3
1996 6
1997 2
1998 2
1999 3
2000 3
2001 3
2002 3
2003 5
2004 6
2005 6
2006 6
2007 5
2008 5
2009 7
2010 11
2011 7
2012 6
2013 4
2014 5
2015 4
2016 1
2017 1
2018 1
2019 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M; German Low Grade Lymphoma Study Group (GLSG); European Mantle Cell Lymphoma Network. Hoster E, et al. Among authors: wandt h. Blood. 2008 Jan 15;111(2):558-65. doi: 10.1182/blood-2007-06-095331. Epub 2007 Oct 25. Blood. 2008. PMID: 17962512 Free article.
Prophylactic platelet transfusion.
Wandt H, Schäfer-Eckart K, Ehninger G. Wandt H, et al. N Engl J Med. 2013 Aug 8;369(6):577. doi: 10.1056/NEJMc1307163. N Engl J Med. 2013. PMID: 23924012 No abstract available.
Platelet transfusion in hematology, oncology and surgery.
Wandt H, Schäfer-Eckart K, Greinacher A. Wandt H, et al. Dtsch Arztebl Int. 2014 Nov 28;111(48):809-15. doi: 10.3238/arztebl.2014.0809. Dtsch Arztebl Int. 2014. PMID: 25512006 Free PMC article. Review.
In Reply.
Wandt H, Schäfer-Eckart K, Greinacher A. Wandt H, et al. Dtsch Arztebl Int. 2015 Jul 20;112(29-30):506. doi: 10.3238/arztebl.2015.0506. Dtsch Arztebl Int. 2015. PMID: 26249255 Free PMC article. No abstract available.
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G; Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation; German Adjuvant Breast Cancer Study Group; University of California, San Francisco. Kröger N, et al. Among authors: wandt h. Bone Marrow Transplant. 2003 Dec;32(12):1153-7. doi: 10.1038/sj.bmt.1704291. Bone Marrow Transplant. 2003. PMID: 14647269 Review.
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornhäuser M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, Kölling K, Stobernack HP, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Champlin RE, Ehninger G; AIC246 Study Team. Chemaly RF, et al. N Engl J Med. 2014 May 8;370(19):1781-9. doi: 10.1056/NEJMoa1309533. N Engl J Med. 2014. PMID: 24806159 Free article. Clinical Trial.
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Knop S, Engelhardt M, Liebisch P, Meisner C, Holler E, Metzner B, Peest D, Kaufmann M, Bunjes D, Straka C, Fischer T, Sezer O, Hentrich M, Ostermann H, Bassermann F, Hess G, Hertenstein B, Freund M, Kropff M, Schmidt CA, Wolf HH, Jung W, Frickhofen N, Mielke S, Bargou RC, Maschmeyer G, Svaldi M, Langer CH, Gramatzki M, Hebart H, Kanz L, Einsele H; Deutsche Studiengruppe Multiples Myelom. Knop S, et al. Leukemia. 2019 Nov;33(11):2710-2719. doi: 10.1038/s41375-019-0537-2. Epub 2019 Aug 28. Leukemia. 2019. PMID: 31462732 Clinical Trial.
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.
Einsele H, Knop S, Vogel M, Müller J, Kropff M, Metzner B, Langer C, Sayer H, Jung W, Dürk HA, Salwender H, Wandt H, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Engelhardt M, Fischer T, Liebisch P, Straka C. Einsele H, et al. Among authors: wandt h. Leukemia. 2017 Jun;31(6):1463-1466. doi: 10.1038/leu.2017.83. Epub 2017 Mar 15. Leukemia. 2017. PMID: 28293022 No abstract available.
110 results